| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.092 | 0.2 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.098 | 0.2 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |